Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Barts Health NHS Trust
2nd Floor, 9 Prescot Street
Aldgate
E1 8PR
UK
Contact person: Mr Fabien Affonso
Telephone: +44 20737770004103
E-mail: Fabien.Affonso@nhs.net
NUTS: UK
Internet address(es)
Main address: http://www.bartshealth.nhs.uk
Address of the buyer profile: http://www.bartshealth.nhs.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Stem Cell Storage
Reference number: DN226217
II.1.2) Main CPV code
38434550
II.1.3) Type of contract
Services
II.1.4) Short description
The service provider shall provide comprehensive stem cell storage and processing for the purchaser, Barts Health NHS Trust.
All activities must comply with direction given under the Human Tissue Acts 2004 (HTA) and any subsequent Direction given by the HTA and JACIE Accreditation and European Union Directive (EUD) 2004/23EC, ‘Setting standards on quality and safety for the donation, procurement, testing processing, preservation, storage and distribution of tissue and cells’ and the implementing EUD 2006/17EC and EUD2006/86EC.
The service provider stem cell laboratory will provide all necessary resources in line with health and safety, COSHH and Hospital policies inclusive of support staff, equipment or plant, consumables and other facilities, which are necessary for the efficient and effective operation of the agreement on the service’s sites.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1 137 600.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33000000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
All activities must comply with Direction given under the Human Tissue Acts 2004 (HTA) and any subsequent direction given by the HTA and JACIE Accreditation and European Union Directive (EUD) 2004/23EC, ‘Setting standards on quality and safety for the donation, procurement, testing processing, preservation, storage and distribution of tissue and cells’ and the implementing EUD 2006/17EC and EUD2006/86EC.
To ensure the continued access for patients to clinical trials providing them with access to novel therapies (e.g. ATIMP/GTC) the provider must have experience of working to MHRA standards in cell therapies.
The harvesting of cells from patients or donors will take place at Barts Hospital. The cells will then be transported to the service provider’s stem cell laboratory, where processing including positive or negative selection, freezing and storage, if necessary are undertaken. The service provider is required to receive and process and return non-frozen and/or cry preserved haematopoietic stem cells/bone marrow for patients requiring transplant at Barts.
The service provider stem cell laboratory will provide all necessary resources in line with health and safety, COSHH and hospital policies inclusive of support staff, equipment or plant, consumables and other facilities, which are necessary for the efficient and effective operation of the agreement on the service’s sites.
Both parties (purchaser and provider) must ensure that the premises, facilities, equipment and materials used by them are fit for purpose and that they are selected, maintained and used in accordance with sections equipment and material, facilities and premises of the guide to quality and safety assurance for human tissue and cells for Patient Treatment Nov 2010 implementing Direction 003/2010 and paragraph 33 of Direction 002/2007 and with paragraphs 36-44 Directions 002/2007 (this is for activities performed on behalf of the Licence Holder).
II.2.5) Award criteria
Quality criterion: Quality and technical aspects
/ Weighting: 70
Price
/ Weighting:
30
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.6) Information about electronic auction
An electronic auction will be used
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.9) Information about termination of call for competition in the form of a prior information notice
The contracting authority will not award any further contracts based on the above prior information notice
Section V: Award of contract
Contract No: 11-2018-1000002827
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
26/09/2018
V.2.2) Information about tenders
Number of tenders received: 2
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 2
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Trustees of the London Clinic Ltd
London
W1G 6BW
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1 137 600.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Barts Helath NHS Trust
London
E1 8PR
UK
VI.5) Date of dispatch of this notice
10/06/2019